Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine
- 211 Downloads
To determine the suitability of the nine-hole box to characterise mouse performance on a free operant task and a discrete trials task, and to validate the tests by probing whether d-amphetamine and scopolamine modify performance of the task as predicted.
To demonstrate the functionality and efficiency of the mouse nine-hole box for the evaluation of performance under fixed- (FR) and progressive-ratio (PR) operant schedules, as well as under a three-choice visual discrimination task and subsequent reversals of the task. In addition, sensitivity of the apparatus was assessed using pharmacological challenges.
C57BL/6J were tested on CRF, FR5, FR10, FR20, and a modified PR3 schedule. Behavioural response to d-amphetamine sulphate (0.1, 0.3, and 2.0 mg/kg for FR and 0.1, 0.3, and 1.0 mg/kg for PR) was assessed. In a separate group of mice trained on a three-choice visual discrimination task, the task was reversed (light+, dark+, light+, dark+) 3 times to determine acquisition and reversal of the visual discrimination rule. Scopolamine hydrobromide was examined in this paradigm with the reversal task, and was used to determine learning acquisition and rule reversal learning.
Mice rapidly acquired the FR and PR schedules, as well as both three-choice visual discrimination procedures in the nine-hole box. d-Amphetamine significantly reduced performance on the FR5 and FR10 schedules as shown by the reduction in the number of rewarded responses and the increases in various latency measurements. As expected, d-amphetamine induced an increase in the break point and eliminated the pauses that occurred on high ratio schedules under the PR3 paradigm. Pretreatment of scopolamine decreased accuracy in the three-choice visual discrimination task.
The nine-hole box is an effective tool to assess operant behaviours in mice following pharmacological manipulation validating the utility of this apparatus for the behavioural evaluation of drug-induced and transgenic models of neurodegenerative disorders.
KeywordsOperant Mouse Fixed-ratio Progressive-ratio Drugs Visual discrimination
Dr. J.C. Bensadoun was supported by the Swiss National Science Foundation. The work was funded by grants from the MRC and the BBSRC.
- Cheal M (1981) Scopolamine disrupts maintenance of attention rather than memory processes. Behav Neurol Biol 33:163–187Google Scholar
- Depoorte R, Perrault G, Sanger DJ (1999) Intracranial self-stimulation under a progressive ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacology 142:221–229Google Scholar
- Durkin TP, Cazala P, Garcia R (2000) Trans-synaptic mechanisms controlling cholinergic neuronal activation in the septo-hippocampal and the nBM-cortical cholinergic pathways: differential roles in memory and attentional processes ? In: Numan R (ed) The behavioural neuroscience of the septal region. Springer, New York, pp 146–174Google Scholar
- Everitt BJ, Robbins TW (1997). Central cholinergic systems and cognition. Ann Rev Psychol 48:649–684Google Scholar
- Glick SD, Muller RU (1971) Paradoxical effects of low doses of d-amphetamine in rats. Psychopharmacologia 22:396–402Google Scholar
- Jones DNC, Higgins GA (1995) Effect of scopolamine on visual attention in rats Psychopharmacology 120:142–149Google Scholar
- Poncelet M, Chermat R, Soubrie P, Simon P (1983) The progressive ratio schedule as a model for studying psychomotor stimulant activity of drugs in the rat. Psychopharmacology 80:184–189Google Scholar